ctx110
crispr,crispr
['carbon study', 'lymphoma', 'crispr']
also happening in #ash22 session 704: dr. joseph mcguirk discussing, ctx110 allogeneic crispr-cas9 engineered car t cells in patients (pts) with relapsed or refractory large b-cell lymphoma: results from the phase 1 dose escalation carbon study. 
We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program